CABOMETYX 60 mg, film-coated tablet 30 tablets
Active ingredients: Cabozantinib S-malate, Cabozantinib
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CABOMETYX 60 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s) avec sécurité enfant
- Marketing authorisation holder
- IPSEN PHARMA
- Reimbursement according to BDPM
- 100%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Cancer du rein avancé, dans certains cas précis uniquement<br>- Cancer du foie, dans certains cas précis uniquement ; JOURNAL OFFICIEL ; 15/02/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Feb 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68164846CIP73007354CIP133400930073544Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CABOZANTINIBcomprimé | 60 mg · un comprimé | FT |
| (S)-MALATE DE CABOZANTINIBcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.